Testing Cartridges for the i-STAT ® System:

at the bedside
The i-ST­­AT System: A Comprehensive Menu of
EXPECTED VALUES
Accelerating decision-making Tests in a Single Platform
Reportable
Range
Reference
Range
Arterial
Reference
Range
Venous
at the patient’s bedside…
100-180 mmol/L (mEq/L) 138-146 mmol/L (mEq/L) 138-146 mmol/L (mEq/L) The fully automated i-STAT System offers a broad menu
2.0-9.0 mmol/L (mEq/L) 3.5-4.9 mmol/L (mEq/L 3.5-4.9 mmol/L (mEq/L)
of tests for diagnostic and treatment indicators related to
disease state management and clinical practice guidelines.
65-140 mmol/L (mEq/L) 98-109 mmol/L (mEq/L) 98-109 mmol/L (mEq/L)
Using just two or three drops of blood, the system provides
5-50 mmol/L (mEq/L) 23-27 mmol/L (mEq/L) 24-29 mmol/L (mEq/L) time-sensitive tests at the patient’s bedside in just minutes.
(-10)-(+99) mmol/L (mEq/L) 10-20 mmol/L (mEq/L) 10-20 mmol/L (mEq/L)
0.25-2.50 mmol/L
1.0-10.0 mg/dL
1.12-1.32 mmol/L
4.5-5.3 mg/dL
1.12-1.32 mmol/L
4.5-5.3 mg/dL
Benefits of the i-STAT System
1.1-38.9 mmol/L 3.9-5.8 mmol/L 3.9-5.8 mmol/L •S
 upports a patient-centric approach to health care
20-700 mg/dL 70-105 mg/dL 70-105 mg/dL
3-140 mg/dL (BUN) 8-26 mg/dL (BUN) 8-26 mg/dL (BUN) that accelerates patient care decision-making by reducing
1-50 mmol/L (Urea)† 2.9-9.4 mmol/L (Urea)† 2.9-9.4 mmol/L (Urea)† the time to get needed information to the clinicians
0.2-20.0 mg/dL 0.6-1.3 mg/dL 0.6-1.3 mg/dL
18-1768 µmol/L 53-115 µmol/L 53-115 µmol/L •O
 ptimises system efficiency by eliminating process
0.30-20.00 mmol/L 0.36-1.25 mmol/L 0.90-1.70 mmol/L
2.7-180.2 mg/dL 3.2-11.3 mg/dL 8.1-15.3 mg/dL steps and handoffs to help reduce the incidence of
errors and promote patient safety
10-75 %PCV 38-51 %PCV 38-51 %PCV
0.10-0.75 Fraction 0.38-0.51 Fraction 0.38-0.51 Fraction •S
 upports quality and compliance requirements The i-STAT System complements
3.4-25.5 g/dL 12-17 g/dL 12-17 g/dL that complement the vital services that laboratory
34-255 g/L 120-170 g/L 120-170 g/L the clinical laboratory’s efforts by
professionals provide to patients and their caregivers
providing lab-quality results for the
6.50-8.2 7.35-7.45 7.31-7.41 •L
 everages the power of a single, integrated most commonly used tests while
5-130 mmHg 35-45 mmHg 41-51 mmHg bedside testing solution through: improving efficiency throughout
0.67-17.33 kPa 4.67-6.00 kPa 5.47-6.80 kPa
5-800 mmHg 80-105 mmHg – a comprehensive menu of tests the continuum of care.
0.7-106.6 kPa 10.7-14.0 kPa
5-50 mmol/L (mEq/L) 23-27 mmol/L (mEq/L) 24-29 mmol/L (mEq/L) –a
 single testing system, rather than multiple
systems and protocols
1.0-85.0 mmol/L (mEq/L) 22-26 mmol/L (mEq/L) 23-28 mmol/L (mEq/L)
Learn more about these and other technology,
– standardised lab-quality bedside testing
(-30)-(+30) mmol/L (mEq/L) (-2)-(+3) mmol/L (mEq/L) (-2)-(+3) mmol/L (mEq/L) process, and service innovations at:
0-100 % 95-98 % – s implified implementation, training, and www.abbottpointofcare.com
regulatory requirements
74-137 Seconds (Prewrm) 74-137 Seconds (Prewrm)
50-1000 Seconds 82-152 Seconds (Nonwrm) 82-152 Seconds (Nonwrm) –a
 system that is lightweight, portable, and
74-125 Seconds (Prewrm) 74-125 Seconds (Prewrm) easy to use
50-1000 Seconds
84-139 Seconds (Nonwrm) 84-139 Seconds (Nonwrm)

0.9-8.0 INR**

0.00-50.00 ng/mL (µg/L) 0.00-0.08 ng/mL (µg/L)*** © Abbott Point of Care Inc.
400 College Road East, Princeton, NJ 08540
0.0-150.0 ng/mL (µg/L) 0.0-3.5 ng/mL (µg/L)# (609) 454-9000
(609) 419-9370 (Fax)
15-5000 pg/mL (ng/L) <15-50 pg/mL (ng/L)#
www.abbottpointofcare.com
* Calculated.
** Performance characteristics have not been established for INR values over 6.0. i-STAT is a registered trademark of the
*** Represents the 0-99% range of results. Abbott Group of Companies in various jurisdictions.
#
Represents the 0-95% range of results. 022865 International Rev.B 06/11
†
Urea customisable to mg/dL and g/L.
 Providing Lab-Quality Results in Minutes:

A wide range of cartridges for diagnostic testing*

CARTRIDGES Additional InTENDED Use
Specifications
EC8+ CG8+ EG7+ CHEM8+ EG6+ CG4+ 6+ G3+ EC4+ E3+ G Crea ACTk ACTc PT/INR cTnl CK-MB BNP
Coagulation

Chemistries/Electrolytes ACT Kaolin

Sodium (Na) The i-STAT Kaolin Activated Clotting Time (Kaolin ACT) test is an in vitro diagnostic
test that uses fresh whole blood to monitor high-dose heparin anticoagulation
Potassium (K)
frequently associated with cardiovascular surgery.
Chloride (Cl)
ACT Celite®
TCO2 2 month
The i-STAT Celite ACT test is useful for monitoring patients receiving heparin
room temperature
Anion Gapa for treatment of pulmonary embolism or venous thrombosis, and for monitoring
storage
Ionised Calcium (iCa) anticoagulation therapy in patients undergoing medical procedures such as
catheterisation, cardiac surgery, surgery, organ transplantation, and dialysis.
Glucose (Glu)

Urea Nitrogen (BUN)

PT/INR
The i-STAT PT, a prothrombin time test, is useful for monitoring patients
Creatinine (Crea)
receiving oral anticoagulation therapy such as Coumadin® or warfarin.
Lactate

Haematology
Cardiac Markers
Haematocrit (Hct)

Haemoglobin (Hgb)a cTnI

The i-STAT cTnI test is an in vitro diagnostic test for the quantitative measurement
Blood Gases of cardiac troponin I (cTnI) in whole blood or plasma samples. Measurements of
pH cardiac troponin I are used in the diagnosis and treatment of myocardial infarction
and as an aid in the risk stratification of patients with acute coronary syndromes
PCO
2 with respect to their relative risk of mortality.
PO2
CK-MB
TCO2a
The i-STAT CK-MB test is an in vitro test for the quantitative measurement of
HCO3a creatine kinase MB mass in whole blood or plasma samples. CK-MB measurements
Base Excess (BE)a can be used as an aid in the diagnosis and treatment of myocardial infarction (MI).

sO2a BNP
The i-STAT BNP test is an in vitro diagnostic test for the quantitative measurement
Coagulationb
of B-type natriuretic peptide (BNP) in whole blood or plasma samples using EDTA
ACT Kaolin as the anticoagulant. BNP measurements can be used as an aid in the diagnosis
ACT Celite® and assessment of the severity of congestive heart failure.

PT/INR
See CTI sheets for full details at: www.abbottpointofcare.com
Cardiac Markersb

cTnl
Coumadin is a registered trademark of Bristol-Myers Squibb.
CK-MB

BNP

a
 alculated.
C
b
See Intended Use on inside right panel. .
Celite is a registered trademark of Celite Corporation, Santa Barbara, CA for its diatomaceous earth products. * For in vitro diagnostic use only.